genome

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.

Nashville Biosciences and Illumina announce sequencing agreement with Amgen

Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.

U.S. precision medicine research program releases genomic data

The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants.

Cellular factor helps package flu genome

New insights on influenza genome packaging could guide strategies for interfering with the virus’s life cycle and ability to cause infection.

DNA damage response protein

Vanderbilt researchers have determined that a previously uncharacterized protein responds to DNA replication stress and has an essential role in maintaining the integrity of the genome.

Rheumatoid subtypes explored by PheWAS

A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.

Genome-editing pioneer next up in Discovery Lecture series

Jennifer Doudna, Ph.D., recipient of a 2015 Breakthrough Prize in Life Sciences, will deliver the next Flexner Discovery Lecture on Thursday, Jan. 8.